Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3048 results

Sort By:

Combined Circulatory and Dietary Interventions for Neuropathy

Study ID: NCT07213843
Start Date: 2026-10-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

INF® Therapy

NVIf

Sponsor

Loma Linda University

Source: clinicaltrials.gov

Share:
Add to list

OverStitch NXT Endoscopic Suture System

Study ID: NCT07276815
Start Date: 2026-07-31
End Date: 2029-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

136

Intervention / Treatment

OverStitch NXT Endoscopic Suture System

Sponsor

Boston Scientific Corporation

Source: clinicaltrials.gov

Share:
Add to list

Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma

Study ID: NCT06093425
Start Date: 2026-06-30
End Date: 2030-01-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

820

Intervention / Treatment

Pembrolizumab and either Capcecitabine + Oxaliplatin or Oxaliplatin+Leucovorin + 5-fluorouracil

Pembrolizumab and either Capcecitabine + Oxaliplatin or Oxaliplatin+Leucovorin + 5-fluorouracil

Sponsor

Suzhou Transcenta Therapeutics Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Timed Aspirin Chronobiome Study

Study ID: NCT03590821
Start Date: 2027-12
End Date: 2028-11
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

60

Intervention / Treatment

Aspirin 81 mg

Celecoxib 200mg capsule

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

SYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell Carcinoma

Study ID: NCT07417735
Start Date: 2026-03-18
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

436

Intervention / Treatment

SYS6010

Investigator's Choice of Chemotherapy (Irinotecan hydrochloride，Paclitaxel，Docetaxel)

Sponsor

CSPC Megalith Biopharmaceutical Co.,Ltd.

Source: clinicaltrials.gov

Share:
Add to list

CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)

Study ID: NCT07165678
Start Date: 2026-09-30
End Date: 2028-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

CTCA

Sponsor

Queen Mary University of London

Source: clinicaltrials.gov

Share:
Add to list

A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

Study ID: NCT07412704
Start Date: 2026-05-28
End Date: 2030-09-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

84

Intervention / Treatment

BMS-986528

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

Methylphenidate and Response to Alcohol Cues

Study ID: NCT07306078
Start Date: 2026-05
End Date: 2028-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Methylphenidate Pill

Placebo Pill

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan

Study ID: NCT06864585
Start Date: 2026-03-15
End Date: 2029-03-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

59

Intervention / Treatment

Avibactam sodium/Ceftazidime hydrate

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria

Study ID: NCT07403643
Start Date: 2026-04
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

60

Intervention / Treatment

Single dose tafenoquine (10 mg/kg)

Dihydroartemisinin-piperaquine (DHA-PPQ)

Artemether + Lumefantrine

Sponsor

Curtin University

Source: clinicaltrials.gov

Share:
Add to list